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Abstract
Nigella sativa had been documented to possess many therapeutic functions in medicine but the least expected
is sero-reversion in HIV infection which is very rare despite extensive therapy with highly active anti-retroviral therapy
(HAART). This case presentation is to highlight the complete recovery and sero-reversion of adult HIV patient after
treatment with Nigella sativa concoction for the period of six months. The patient presented to the herbal therapist with
history of chronic fever, diarrhoea, weight loss and multiple papular pruritic lesions of 3 months duration. Examination
revealed moderate weight loss, and the laboratory tests of ELISA (Genscreen) and western blot (new blot 1 & 2)
confirmed sero-positivity to HIV infection with pre-treatment viral (HIV-RNA) load and CD4 count of 27,000
copies/ml and CD4 count of 250 cells/ mm3 respectively. The patient was commenced on Nigella sativa concoction
10mls twice daily for 6 months.. He was contacted daily to monitor side-effects and drug efficacy. Fever, diarrhoea and
multiple pruritic lesions disappeared on 5th, 7th and 20th day respectively on Nigella sativa therapy. The CD4 count
decreased to 160 cells/ mm3 despite significant reduction in viral load (≤1000 copies/ml) on 30th day on N. sativa.
Repeated EIA and Western blot tests on 187th day on Nigella sativa therapy was sero-negative. The post therapy CD4
count was 650cells/ mm3 with undetectable viral (HIV-RNA) load. Several repeats of the HIV tests remained sero-
negative, aviraemia and normal CD4 count since 24 months without herbal therapy. This case report reflects the fact
that there are possible therapeutic agents in Nigella sativa that may effectively control HIV infection.
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Introduction
HIV infection was regarded by scientists as the worst epidemic in recent decades and almost 2/3rd of the 33.3
million infected people live in Africa (UNAIDS, 2010). No infectious disease or organism claimed 1.8 million of both
adult and children lives in a year (2009) except HIV/AIDS. Despite efforts on availability of free treatment of the
infection, only 5.2 million of 22.5 million people living with HIV/AIDS in Africa could access free antiretroviral
therapy in 2009 (UNAIDS, 2010). All the attempts to cure the HIV infection proved abortive although progress had
been made on controlling almost all the steps involved in the viral replication cycle (Kindt et al, 2007).
Introduction of highly active antiretroviral therapy (HAART) had effectively reduced the death associated
with HIV infection. Although many of the HIV patients on HAART recover from HIV/AIDS infection and become
aviraemia within 100 days of commencement of therapy but sero-reversion is very rare (Abbas et al, 2000; Finzi &
Siliciano, 1998 and Kindt et al, 2007). Few cases of sero-reversion in HIV patients occurred at early stage of HIV
infection or in children of HIV infected mothers (Coyne et al, 2007; Jurriaans et al, 2004 and Kassutto et al, 2005). The
general dogma of un-curability of HIV infection had been challenged by recent spontaneous and drug induced complete
recovery with sero-reversion (Onifade et al, 2012). Even herbal therapy had been associated with sero-reversion and
full recovery from HIV/AIDS (Lu et al, 1997 and Onifade et al, 2012).
Herbal remedy is a substance that contains active ingredients which are parts of plants or plant materials, or
combinations used to treat a multitude of ailments throughout the world (WHO, 2002). Many herbal remedies had
played many roles in treatment of HIV/AIDS ranging from opportunistic infections to the inhibition of the viral
replication (Cos et al, 2008 and Kong et al, 2003). Tat (p14 regulatory protein that activates proviral DNA
transcription) had been documented to be inhibited by pentosan poly-sulphate, a carbohydrate derivative (Watson et al,
1999). Reverse transcription and HIV induced cell fusion is also inhibited by Ancistrocladus korupensis, a liana
(Matthee et al, 1999). A canolide (coumarin) from tropical forest tree (Calophyllum lanigerum) was documented to
possess non-nucleoside reverse transcriptase inhibitory potential in potency (Dhamaratne, et al 2002). Some Chinese
medicines have been reported to cause sero-reversion in HIV patients (Lu et al 1997).
Nigella sativa is a popular herb that have been in use in many forms (root, leaf and seed) since many
centuries as dated in Islamic and Christian history (Al-Bukhari, 1976 and Isaiah). It is widely available in Asia and
Mediterranean regions. Many research studies have been documented on the attributed role of Nigella sativa in
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treatment of various ailments ranging from infectious to non-infectious diseases (Rhandhawa, 2008). N. sativa was
documented to increase T helper cell and other leucocytes (Bamosa et al, 1997 and El-Kadi & Kandil, 1986). The
accelerating wound healing effect of N. sativa had been established in rats and humans (Ahmed et al, 1995). It has
potent anti-inflammatory, pyrexic and analgesic effects (Al-Ghamdi, 2001 and Houghton et al, 1995). It has been
demonstrated to be useful in ameliorating allergic diseases (Badar, 1960). Nigella sativa was documented to be potent
antimicrobial agent on bacteria, fungi, protozoa and viruses (Topozada et al, 1965; Alijabre et al, 2005 and Akhtar &
Riffat, 1991). However, its antiretroviral (HIV) efficacy had not been well documented, thus propelling the reporting of
this presentation.
Case Presentation
YB (25/Os), a 46 year old man, was an artisan (panel beater) who was recruited via the herbalist into the
prospective (doctoral) research study and presented with fever, diarrhoea, weight loss and malaise of 3 months
duration. He had multiple popular pruritic skin lesions and weight loss evidenced by prominent zygomatic process with
sero-positivity to HIV tests (ELISA and confirmed by Western blot). The pre-treatment CD4 count and viral (HIV-
RNA) load were 250cells/mm3 and 27, 000 copies/ml respectively. Herbal therapist commenced treatment by
dispensing 10mls three times daily of Nigella sativa concoction for 4 months effective from August 2009. He was
monitored daily and visited regularly to ascertain the effectiveness of the herbal concoction. However, because of the
patient’s occupation schedule (worked 7am - 7pm daily), he could only take the medication twice daily, thus lasting for
almost 6 months (January 2010). The fever, malaise and diarrhoea disappeared on the 5th and 7th day respectively. The
multiple papular pruritic lesions disappeared on the 20th day. However, the 1st monthly CD4 count was reduced
drastically (160 cells/ mm3) despite rapid clinical improvement and significant viral (HIV-RNA) load (1000 copies/ml).
Surprisingly, the CD4 count increased gradually from the 2nd month and viral load became undetectable. The CD4
count and viral (HIV-RNA) repeated at the end of therapy were 650cells/ mm3 and undetectable (≤ 50copies/ml) 
respectively. HIV screening (EIA) and Western blot were repeated on 187th day on herbal concoction therapy and were
both negative. The patient was followed up regularly with repeated HIV screening, confirmation (Western blot), CD4
count and viral (HIV-RNA), with all showing sero-negativity and undetectable viral load with normal CD4 count
(≥750cells/ mm3). The patient was not on HAART before, during or after the Nigella sativa concoction therapy.
Table 1: Monthly CD4 count, viral load and HIV tests of the patient
PERIOD CD4 count (cells/
mm3
Viral (HIV-RNA) load
(copies/ml)
HIV tests (EIA & Western
blot)
0th (pre-treatment) 250 27,000 Positive
1st month  160 ≤1,000 Positive 
2nd month 190 ≤50 Positive 
3rd month 270 ≤50 Positive 
4th month 420 ≤50 Positive 
5th month (Jan 2010) 540 ≤50 Weakly positive 
6th month (Feb 210) 650 ≤50 Negative 
8th  month  830 ≤50 Negative 
12th month (a year) 840 ≤50 Negative 
18thmonth(Feb 2011) 820 ≤50 Negative 
24th month (2nd year) 880 ≤50 Negative 
30th month (3rd year) 790 ≤50 Negative 
36thmonth(Feb 2012) 850 ≤50 Negative 
44th month (Oct 2012) 870 ≤50 Negative 
47th month (Jan 2013) 880 ≤50 Negative 
Comments
The un-scientific claims by herbal therapists on diseases led to the research study to determine the
effectiveness of herbal remedies in HIV infection. Although HIV infection and un-expected treatment outcome (sero-
reversion) had generated controversy, investigational research and reporting could help in the confirmation or rejection
of documented claims in many parts of the world. There are many documented roles of herbal remedies in treatment of
diseases but sustained sero-reversion and complete recovery was the least expected in HIV infection. Sero-reversion
and complete recovery of HIV patient taking Nigella sativa had not been reported despite many pharmacologic and
therapeutic functions associated with the herbal products from this plant (Al-Ghamdi, 2001; Aljabre et al, 2005;
Bamosa et al, 1997; Houghton et al, 1995; Morsi, 2000; Randhawa, 2008).
The initial decline in CD4 count despite significant clinical improvements by N. sativa concoction is an
indication that CD4 count is not enough to monitor the effectiveness of herbal therapy in HIV infection. Likewise 3–
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month CD4 count is not adequate to determine efficacy of therapy in HIV infection. This is confirmed by significant
decrease in viral (HIV-RNA) load with disappearance of signs and symptoms associated with HIV infection in this
patient. This is in contrary to the general knowledge that effective antiretroviral therapy (HAART) increases the CD4
count and reduces viral load significantly within 100 days of commencement with therapy. This patient’s case despite
poor adherence to medication (twice daily medication instead of thrice as prescribed by herbal therapist) is in support
of earlier findings that herbal remedies are not only effective in HIV infection but caused sustained sero-reversion (Lu
et al, 1997 and Onifade et al, 2012).
HIV patients on HAART normally experience rapid decrease in viral load with increase in CD4 count due to
inhibition of steps in viral replication. Thus, HAART is virustatic. Nigella sativa concoction is likely to be virucidal
because viral load reduced significantly and symptoms and signs associated with HIV infection disappeared despite
reduction in CD4 count at early phase of treatment in this patient. This is in support of earlier studies that Nigella sativa
and protease inhibitor (Ro 31-8959) selectively lyse viral infected cells (Levin et al, 2010 and Rhandawa, 2008). The
likely virucidal effect of Nigella sativa therapy on HIV infected cells might explain the initial decrease in CD4 count
due to excess CD4 T cell lysis when compared to lymphoiesis. This is confirmed by significant viral load reduction to
undetectable level within 3 months commensurable with HAART.
The sustained sero-reversion caused by Nigella sativa might be due to complete absence of HIV infected
cells from the body like ‘Berlin’ patient (Hutter et al 2009). Because the half-life of circulating IgM and IgG are 5 and
23 days respectively, absence of the virus (antigen) would halt further B or plasma cell secretion. Because productive
short half-life (24 hours) CD4 T cells produce 93-97% of plasma virus, their rapid lysis or viral replication inhibition
would cause viral load reduction to undetectable level on antiretroviral therapy. However, HIV from productively
infected long lived macrophage (14 days), resting or memory CD4 T cells (about 50 years) that account for 1-7%
plasma HIV, continue to evoke antibody production (Finzi and Siliciano, 1998).
It was concluded that the sustained sero-reversion induced by Nigella sativa concoction in this HIV patient
means that all HIV cells at all stages in infected cells in the body must have been lysed. Therefore, there is need to
further study more HIV patients on Nigella sativa therapy and its virucidal effect on this pandemic virus.
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